Active Comparator Drug,Active Comparator Drug,Active Comparator Drug,Active Comparator Drug

2 trials

Sponsors

Department of Medicine, Chulabhorn International College of Medicine (CICM) at Thammasat University, Health System Research Institute

Conditions

Helicobacter pylori infection vonoprazan, dual therapy, triple therapy, Helicobacter pylori eradicationHypercholesterlemia Hypercholesterlemia, Low Density Lipoprotein-Cholesterol, LDL-C

Phase 4

Efficacy of vonoprazan-based dual therapy and vonoprazan-based triple therapy for Helicobacter pylori eradication: A prospective randomized study

Active, not recruitingTCTR20210623008

Department of Medicine, Chulabhorn International College of Medicine (CICM) at Thammasat UniversityHelicobacter pylori infection vonoprazan, dual therapy, triple therapy, Helicobacter pylori eradication

Start: 2021-01-12Target: 100Updated: 2026-08-03

Short term efficacy and safety of generic rosuvastatin (K-zuva) versus brand rosuvastatin (Crestor) for the treatment in patients with hypercholesterolemia

TCTR20221209001

Health System Research InstituteHypercholesterlemia Hypercholesterlemia, Low Density Lipoprotein-Cholesterol, LDL-C

Start: 2020-03-03Target: 240Updated: 2026-08-03